Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

Resverlogix Corp > cost basis
View:
Post by general360 on Nov 04, 2020 2:37pm

cost basis

boy oh boy is it a mess....does anyone know what the cost basis of RVX and ZEN is?

from the spin out, looks like the shares left behind are all out of whack... i havent looked too closely - until now-
the zen capital corp vs zen capital corporation also seems to be throwing a monkey wrench into it.  i just spent about 30m on the phone w/ broker, still not sure i fully understand but as per usual, my understanding isnt important!  what is, is that the brokerage says everything is fine....

cost basis was explained as:  post split = 1% rvx and 99% zen?   so they took my shares, total price, allocated 1% of it to RVXCF and divided by total number of shares, giving me a new cost basis for RVXCF.  looks like i was a mad genius and paid .02 to .04 cents per share back in 2010 and 2013.  They took 99% of total price, divided by same shares and came up with some crazy #'s. the same lots of zen show up w/ a cost basis of $24 to 34$.  im scratching my head cause i think these were bought in the $2/$3/$4 range...

also showing zhclf is trading.  they think its correct, but i tried to explain the zen cap corp vs zen capital corporation but i dont think thats working.  they think it's an epigenetics company  in name so it must be right?!?!  there are no assurances that i can get shares of this now, and eventually when someone figures the spaghetti out - will i still have all these shares in actual zen epigenetics?!? i guess the good news is i'm apparently so far under water based on their calculations, i'll lose money unless we sell zen for more than 34$/share. i'll have to play with the numbers and see who's who is da zoo...the zen FAQ doesn't help in this case i dont think.  i asked if i bought a whole bunch of shares of ZHCLF now, when this gets untangled, will i still have shares in zen epi, or would it get unwound?  the answer was there are no assurances.  i'm not willing to lock up more money for YEARS more, but i wonder what would happen - buy this zhclf for 4 pennies when they're doing PP's for 1.50?


conversely, apparently i'm sitting on some very large paper gains since i bought this in 2010 and 2013 at MY TWO CENTS!!

is nothing easy w/ this company?!?!?! / companies??

the good news (MORE good news GENERAL?!) is that this isn't an issue until i sell.  the bad news is that we're still held ZEN hostage since its not trading!  kick the can down the road DM style and deal w/ it later, at sale/tax time...  hey, that's an excuse, maybe DM is better off never listing ZEN so he doesnt cause us all this book keeping headache!! or dont make a RVX deal so u dont give us a large tax bill, or push the deal into the new year so ppl can put more into ur RRSP...

GET. IT. DONE.
Comment by ENEMENEMYNEMO on Nov 04, 2020 8:16pm
From similar scenarios in the past... more so when a company goes private...if you hold shares in an existing "non-trading" company you basically have  NOTHING!!!  The majority holder (McCrappity) can do what ever.  Which usually leads to dilution ( in his favour) and nothing for you. You have no say and nothing to sell. The 2013 deal stole value from RVX and put it in ...more  
Comment by narmac on Nov 05, 2020 5:23am
g360,,,,,, this was discussed several times in past on the other board. Zen I think was ruffly 6 or 8% of the floor pricing at the time of the spin out. It may be possible to find that info off there or someone may remember it off hand.
Comment by quest13 on Nov 05, 2020 8:47am
Zenith shows this valuation as Question number 9 on its FAQ page
Comment by quest13 on Nov 05, 2020 9:10am
I have pointed out the valuation FAQ for Zenith Capital Corp. Or as I think of the spin out from RVX in 2103, as ZCC or my broker assigns a non existent symbol of ZENE for reporting on my account. My broker has not been derailed by the ZHCLF screwup. Complicating the situation ZCC has set up a 100% owned subsidiary ZEL or Zenith Epigenetics Limited. It was/is my opinion that the setup of ZEL was ...more  
Comment by general360 on Nov 05, 2020 11:43am
thank you quest!  i hadn't seen the valuation described in Q9 which is exactly what i'm looking for.  i'll have to verifiy my numbers, but my broker told me 1% RVX and 99% Zenith.  that's not right from the FAQ.  i'll have to play with my lots and see if that math works out - either 1 & 99 (like broker said) or 90.9 and 9.1. like ZEN says... i dont ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities